Your Questions, Answered
We’ve assembled the most frequently asked questions about Eversense into one place. Got a question that you can’t find the answer to? Contact us.
The Glucose Statistics report shows your average, low and high glucose readings, along with standard deviation within 6 hour time periods. You can choose the last 1, 7, 14, 30 or 90 days.
The Eversense® CGM is compatible with Glooko.
Syncing data to Glooko is initiated via the user’s Glooko account. They will need to know their Eversense username and password to link their Eversense account via Glooko.
The Eversense® My Circle refers to the group of people you invite (up to 5 people) to remotely view your Eversense® CGM data. To join the Circle, those you invite must accept the invitation they receive from you. They will need to download and install the Eversense® NOW Mobile App in order to see your glucose data.
There may be times when you wish to temporarily stop sharing data with a member, but not remove them from your Circle.
IMPORTANT: If you have disabled the Share My Data feature for a member, that member will not see any of your Eversense® CGM System glucose data, alerts or event history. Members will see your status as Offline on their Eversense® NOW App when you have disabled the Share my Data feature. It can take up to 10 minutes for the change to display on the Eversense® NOW user’s app.
Please visit our Compatibility page for the latest information.
The location services of the android phones are required in order for the Eversense app to scan for Bluetooth devices and pair with the Eversense E3 Smart Transmitter. The Eversense app does not track your location.
Still have questions?
The Eversense team is dedicated and ready to provide the answers and support you need. Simply click the link below.
The Eversense® E3 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to 180 days in persons with diabetes age 18 and older. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are still required for calibration primarily one time a day after day 21, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense E3 CGM System is a prescription device; patients should talk to their health care provider to learn more.
The Eversense® 365 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to one year in people (18 years and older) with diabetes. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are required for calibration one time a week after day 13, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense 365 CGM System is a prescription device; patients should talk to their health care provider to learn more.
For important safety information, see bit.ly/eversensesafety
Eversense, Eversense E3 Continuous Glucose Monitoring, Eversense 365 Continuous Glucose Monitoring, and the Eversense logo are trademarks of Senseonics, Incorporated. Ascensia, the Ascensia Diabetes Care logo are trademarks and/or registered trademarks of Ascensia Diabetes Care Holdings AG. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.
Apple Watch® is a product of Apple, Inc., and may be separately purchased from an authorized Apple retailer. Apple Watch is not included with the Eversense CGM System. Android is a trademark of Google LLC.
PP-SENS-E3-GBL-0060